Dr. Christopher Corless presented a plenary talk at the annual meeting of the Association of Molecular Pathology.
Knight Diagnostic Laboratories’ Executive Director and Chief Medical Officer, Dr. Christopher Corless presented a plenary talk entitled “Applications of Next-Gen Sequencing in Cancer Genotyping: The Good, The Bad, and The Ugly” on November 14, 2013 at the annual meeting of the Association of Molecular Pathology.